MCID: BCK001
MIFTS: 64

Becker Muscular Dystrophy malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Muscle diseases

Aliases & Classifications for Becker Muscular Dystrophy

About this section
Sources:
49OMIM, 32LifeMap Discovery®, 10Disease Ontology, 11diseasecard, 45NIH Rare Diseases, 22GeneTests, 12DISEASES, 51Orphanet, 67UniProtKB/Swiss-Prot, 65UMLS, 47Novoseek, 24GTR, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet, 34MedGen, 36MeSH, 61The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Becker Muscular Dystrophy:

Name: Becker Muscular Dystrophy 49 32 10 11 45 22 12 51 67 65
Benign Pseudohypertrophic Muscular Dystrophy 10 45 65
Bmd 22 51 67
Benign Congenital Myopathy 10 65
Muscular Dystrophy Becker 47 24
 
Becker Dystrophinopathy 45 51
Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type 45
Muscular Dystrophy, Becker Type 45
Becker's Muscular Dystrophy 45

Characteristics:

Orphanet epidemiological data:

51
becker muscular dystrophy:
Inheritance: X-linked recessive; Prevalence: 1-9/100000 (Europe); Age of onset: Childhood; Age of death: any age

HPO:

61
becker muscular dystrophy:
Onset and clinical course: adult onset
Inheritance: x-linked recessive inheritance


Classifications:



External Ids:

OMIM49 300376
Disease Ontology10 DOID:9883
Orphanet51 98895
UMLS via Orphanet66 C0917713
ICD10 via Orphanet28 G71.0
MESH via Orphanet37 C537666
MedGen34 C0917713
MeSH36 D020388
UMLS65 C0699741, C0917713, C3490459

Summaries for Becker Muscular Dystrophy

About this section
OMIM:49 The muscular dystrophy that carries the Becker eponym is similar to Duchenne muscular dystrophy in the distribution of... (300376) more...

MalaCards based summary: Becker Muscular Dystrophy, also known as benign pseudohypertrophic muscular dystrophy, is related to muscular dystrophy, duchenne and becker types and myotonia congenita, recessive, and has symptoms including arrhythmia, calf muscle pseudohypertrophy and muscular dystrophy. An important gene associated with Becker Muscular Dystrophy is DMD (Dystrophin), and among its related pathways are Smooth Muscle Contraction and Muscular Dystrophies and Dystrophin-Glycoprotein Complex. Affiliated tissues include skeletal muscle, heart and bone, and related mouse phenotypes are nervous system and behavior/neurological.

NIH Rare Diseases:45 Becker muscular dystrophy (bmd) is an inherited condition that causes progressive weakness and wasting of the skeletal and cardiac (heart) muscles. it primarily affects males. the age of onset and rate of progression can vary. muscle weakness usually becomes apparent between the ages of 5 and 15. in some cases, heart involvement (cardiomyopathy) is the first sign. bmd is caused by a mutation in the dmd gene and is inherited in an x-linked recessive manner. bmd is very similar to duchenne muscular dystrophy, except that in bmd, symptoms begin later and progress at a slower rate. there is no cure for this condition, and treatment aims to relieve symptoms and improve quality of life. people with bmd may survive into their 40s or beyond. last updated: 11/4/2015

UniProtKB/Swiss-Prot:67 Becker muscular dystrophy: A neuromuscular disorder characterized by dystrophin deficiency. It appears between the age of 5 and 15 years with a proximal motor deficiency of variable progression. Heart involvement can be the initial sign. Becker muscular dystrophy has a more benign course than Duchenne muscular dystrophy.

Related Diseases for Becker Muscular Dystrophy

About this section

Graphical network of the top 20 diseases related to Becker Muscular Dystrophy:



Diseases related to becker muscular dystrophy

Symptoms for Becker Muscular Dystrophy

About this section

Symptoms by clinical synopsis from OMIM:

300376

Clinical features from OMIM:

300376

HPO human phenotypes related to Becker Muscular Dystrophy:

(show all 8)
id Description Frequency HPO Source Accession
1 arrhythmia HP:0011675
2 calf muscle pseudohypertrophy HP:0003707
3 muscular dystrophy HP:0003560
4 myalgia HP:0003326
5 elevated serum creatine phosphokinase HP:0003236
6 cardiomyopathy HP:0001638
7 muscle weakness HP:0001324
8 hyporeflexia HP:0001265

Drugs & Therapeutics for Becker Muscular Dystrophy

About this section

Drugs for Becker Muscular Dystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 185)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tadalafilapproved, investigationalPhase 4, Phase 3, Phase 1140171596-29-5110635
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
ADCIRCA
Acdirca
Adcirca
C429886
CHEBI:41488
CHEMBL779
CID110635
CPD000466321
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
D02008
DB00820
FT-0080116
GF 196960
GF-196960
 
HMS2051N17
HSDB 7303
IC 351
IC-351
ICOS 351
Ic351
KS-1117
LS-186558
LS-187015
LS-187770
Lilly brand of tadalafil
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadanafil
UNII-742SXX0ICT
ZINC03993855
2
Carvedilolapproved, investigationalPhase 415372956-09-32585
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
107741-96-8
72956-09-3
AB1004830
AC-1641
AC1L1E0B
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
Bio-0014
C043211
C06875
C2260
C24H26N2O4
CHEBI:3441
CHEMBL723
CID2585
CPD000449280
Carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilolum
Carvedilolum [Latin]
Coreg
Coreg (TN)
Coreg CR
Coropres
Coropress
D00255
DB01136
DQ 2466
DQ-2466
Dibloc
 
Dilatrend
EG-P042
Eucardic
GlaxoSmithKline brand of carvedilol
HMS2051N03
HMS2089B09
HMS2093E12
HSDB 7044
I06-0064
I06-1477
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
L001243
LS-121875
Lakeside brand of carvedilol
MLS000758299
MLS000759508
MLS001424092
MolPort-003-666-814
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
Querto
Roche brand of carvedilol
SAM001246736
SAM001247021
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
STK621453
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
Spectrum_001665
TL8005080
UNII-0K47UL67F2
carvedilol
carvedilol, (+-)-isomer
carvedilol, (R)-isomer
carvedilol, (S)-isomer
carvedilol, 14C-labeled
3
RamiprilapprovedPhase 414487333-19-55362129
Synonyms:
(2 S ,3 aS ,6 aS )-1[( S )-N-[( S )-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester
(2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester
(2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name)
(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid.
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic
(2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p
(2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]
126613-39-6
87333-19-5
AC-1347
AC1NSFPR
Acovil
Almirall Brand of Ramipril
Altace
Altace (TN)
Altace (tn)
Astra Brand of Ramipril
AstraZeneca Brand of Ramipril
Aventis Brand of Ramipril
Aventis Pharma Brand of Ramipril
BIDD:GT0803
BSPBio_003347
Bio-0651
C23H32N2O5
CHEBI:289203
CHEBI:8774
CHEMBL1168
CID5362129
CPD000466386
Carasel
Cardace
D00421
D017257
DB00178
Delix
HMS2051E04
HMS2090L11
HMS2093M10
HOE 498
HOE498
Hoe-498
Hoechst Brand of Ramipril
 
Hypren
Hytren
KBio2_002504
KBio2_005072
KBio2_007640
KBio3_002849
KBioGR_001858
KBioSS_002512
LS-58199
Lostapres
MLS000759523
MLS001216547
MLS001423965
MolPort-001-736-571
Monarch Brand of Ramipril
N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid
NCGC00178127-01
Naprix
Pramace
Pramace (discontinued)
Promed Brand of Ramipril
Quark
R0404_SIGMA
Ramace
Ramipril
Ramipril (USP/INN)
Ramipril [USAN:INN:BAN]
Ramiprilum
Ramiprilum [Latin]
Ramipro, Tritace, Altace, Prilace, Ramipril
S1793_Selleck
SAM001246757
SAM002699899
SMR000466386
SPECTRUM1505214
STK801937
Spectrum3_001794
Spectrum4_001269
Spectrum5_001721
Spectrum_001958
Triatec
Tritace
UNII-L35JN3I7SJ
Unipril
Vesdil
Zabien
[2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
[2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen
ramipril
4Antihypertensive AgentsPhase 4, Phase 3, Phase 23618
5HIV Protease InhibitorsPhase 4, Phase 3, Phase 24558
6Protease InhibitorsPhase 4, Phase 3, Phase 24558
7Contraceptives, OralPhase 4, Phase 3, Phase 23734
8Angiotensin-Converting Enzyme InhibitorsPhase 4, Phase 3, Phase 2634
9Neurotransmitter AgentsPhase 4, Phase 3, Phase 214795
10Anti-Bacterial AgentsPhase 4, Phase 19140
11Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12926
12Phosphodiesterase InhibitorsPhase 4, Phase 3, Phase 2, Phase 11062
13Adrenergic AgentsPhase 4, Phase 34204
14Phosphodiesterase 5 InhibitorsPhase 4, Phase 3, Phase 2, Phase 1513
15Antibiotics, AntitubercularPhase 45971
16Adrenergic alpha-1 Receptor AntagonistsPhase 4405
17Adrenergic beta-AntagonistsPhase 4979
18Adrenergic AntagonistsPhase 41253
19Adrenergic alpha-AntagonistsPhase 4586
20
Lisinoprilapproved, investigationalPhase 2, Phase 311683915-83-75362119
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Carace
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
LPR
LS-118899
Linopril
Linvas
Lipril
Lisinal
Lisinopril
Lisinopril (INN)
 
Lisinopril (anhydrous)
Lisinopril 10mg
Lisinopril 2.5mg
Lisinopril 20mg
Lisinopril 40mg
Lisinopril 5mg
Lisinopril Dihydrate
Lisinopril anhydrous
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
SMR000544473
SPBio_001351
SPBio_002481
SPECTRUM1501217
Sinopril
Sinopryl
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Spectrum_000497
TL8005499
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
Zestril (TN)
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
lisinopril
21
EnalaprilapprovedPhase 311275847-73-35362032, 40466924
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
75847-73-3
AC1NTUS5
Analapril
BIDD:GT0751
BPBio1_000340
BSPBio_000308
BSPBio_003035
Bonuten
C06977
CAS-76095-16-4
CHEBI:116847
CHEBI:4784
CHEMBL578
CID5388962
D07892
DivK1c_000408
Enalapril
Enalapril (INN)
Enalapril (TN)
Enalapril Bp
Enalapril Maleate
Enalapril Richet
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
 
Enalaprilum [INN-Latin]
Gadopril
HMS2090E08
IDI1_000408
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
Kinfil
LS-190651
MolPort-002-885-877
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NINDS_000408
Prestwick3_000314
SPBio_001349
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
Spectrum_001307
Vaseretic
Vasotec
Vasotec IV
enalapril
22
PrednisoneapprovedPhase 3, Phase 2126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
23
BenzocaineapprovedPhase 316841994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
20/20 Topical Anesthetic
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Alcohol Prep Pads
Allegenal-m
Alpha-caine Topical Anesthetic
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anbesol Jr
Anbesol Maximum Strength
Anbesol Regular Strength
Anestenka
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthetic
Anesthone
Atopalm Oral Pain Relief
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Baby Anestenka
Baby Sensigel
Baby Sensigel Night Time Formula
Baby Teething Oral Pain Reliever
Bactimicina For Sore Throat
Bencocaine Topical Anesthetic
Bensokain
Benz O Sthetic
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzodent
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
Boil Ease
Boy Butter Desensitizing Lubricant
Boy Butter Extreme Desensitizing Lubricant
Boy Butter Extreme H2O Desensitizing Lubricant
Brace Relief
Budpak Baby Teething Oral Pain Reliever
Budpak Oral Maximum Strength
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Carmex Cold Sore Treatment External Analgesic
Caswell No. 430A
Cepacol Fizzlers
Cepacol Sensations Hydra
Cepacol Sensations Sore Throat Hydra citrus splash
Cepacol Sensations Warming
Certus Sting Relief Prep Pad
Chloraseptic
Chloraseptic Warming Sore Throat
Colgate Orabase
Comfortcaine Topical Anesthetic
Cvs Fast Acting Baby Teething
Cvs Maximum Strength
Cvs Maximum Strength Boil Relief
Cvs Oral Anesthetic
Cvs Pharmacy Instant Toothache
Cvs Pharmacy Maximum Strength
Cvs Pharmacy Mouth Sore Gel
Cvs Pharmacy Nighttime Oral Pain Relief
D001566
D00552
DB01086
Dental Relief
Dentek Instant Pain Relief Maximum Strength
Dermoplast
Diet Ayds
DivK1c_000932
Dollar General Toothache Relief
Dukal Sting Relief Pad
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Finafta Baby
Finafta MultiOral
Formate, Benzocaine
Gelato Topical Anesthetic
Good Neighbor Pain Relief
Goodsense Oral Pain Relief
Gps Topical Anesthetic
Gumnumb Topical Anesthetic
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Heb Severe Toothache
Herbasoul Male Genital Desensitizer Cream
 
Hurricaine
Hurricaine Topical Anesthetic
Hurricaine Topical Anesthetic Gel
Hurricaine Topical Anesthetic Liquid
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
Insect Bite Relief
Instant Toothache Pain Relief
Intense Cvs Intense Toothache
Iodent Maximum Strength Oral Analgesic
Ismile Topical Anesthetic
Jianze Sting Relief Pads
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Kank-a Mouth Pain
Keloform
Kmart Smart Sense
Kroger Toothache Pain Relief
LS-35847
Leader Oral Analgesic
Little Colds Sore Throat Relief Melt Aways
MLS001331704
MLS002153970
Makesense Junior Pain Relief
Makesense Pain Relief
Male Desensitizer Pleasure Balm
Mandelay Male Genital Desensitizer
Mark 3
Methanesulfonate, Benzocaine
MolPort-000-871-526
Mouth Sore Medication
Mouth Sore Relief Applicator
Mouth Sore Relief Professional Strength
My Fair Baby Instant Pain Relief
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Nene Dente
Norcain
Norcaine
Norcainum
Opahl
Opahl Dye Free
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orajel For All Mouth Sores Maximum Strength
Orajel For Cold Sores
Orajel For Toothache Maximum Strength
Orajel Instant Pain Relief Maximum Strength
Orajel Instant Pain Relief Regular Strength
Orajel Instant Relief For Teething Pain
Orajel Instant Relief For Teething Pain Cooling Cucumber
Orajel Instant Relief For Teething Pain Daytime Nighttime Twin Pack
Orajel Instant Relief For Teething Pain Longer Lasting
Orajel Maximum Strength
Orajel Nighttime Instant Relief For Teething Pain Longer Lasting Extra Strength
Orajel Severe Toothache Maximum Strength Fast-Acting Formula
Oral Analgesic Maximum Strength
Oral B Instant Pain Relief
Oral Gel Maximum Strength
Oral Pain Relief Anesthetic Anesthetic
Oral Pain Reliever
Oralabs Cold Sore Treatment
Orthesin
Otocain
Outgro
Pac-dent Top Gel
Pain Relief
Pain Relief Alcohol Swabs
Parathesin
Parathesin (TN)
Parathesine
Physicians Care Sting Relief Pad
Pleasure Balm Kama Sutra
Preboost
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
Purelife Topical Anesthetic
Quality Choice Maximum Strength Oral Pain Relieving
Red Cross Oral Pain Relief
Rexall Maximum Strength
Rite Aid Baby Care
Rite Aid Liquid Anesthetic Oral Pain Relief
Rite Aid Maximum Strength
Rite Aid Oral Pain Reliever
Rite Aid Professional Strength
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Sally Hansen Ouch-relief Numbing Wipes
Sally Hansen Ouch-relief Wax Kit
Sally Hansen Ouch-relief Wax Strip Kit
Sensigel
Severe Oral Pain Reliever
Sheffield Baby Teething Gel
Sheffield Pain Relief
Shunga Male Genital Desensitizer
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Sting Relief Medicated Pad
Sting Relief Pads
Tanac
Terrasil Boil Pain Relief
Tiger Supply Inc Topical Anesthetic
Top Quality Mfg. Topical Anesthetic
Topcaine
Topcare Maximum Strength
Topical Anesthetic Banana
Topical Anesthetic Bubble Gum
Topical Anesthetic Cherry
Topical Anesthetic Mint
Topical Anesthetic Pina Colada
Topical Anesthetic Raspberry
Topical Anesthetic Strawberry
UNII-U3RSY48JW5
Ultracare Anesthetic Bubble Gum
Ultracare Anesthetic Butter Rum
Ultracare Anesthetic Creme de Menthe
Ultracare Anesthetic Pina Colada
Ultracare Anesthetic Walterberry
WLN: ZR DVO2
Walgreens Baby Teething
Walgreens Intense Toothache
Walgreens Maximum Strength
Walgreens Pain Relieving For Boils
Walgreens Severe Oral Pain Reliever
Walgreens Severe Toothache Relief
Winco Foods Maximum Strength Oral Analgesic
ZINC12358719
Zilactin-b
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
24
MetforminapprovedPhase 3, Phase 2, Phase 11645657-24-9, 1115-70-414219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMBG
DMGG
Diabefagos
Diabetosan
Diabex
Diaformin
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Meguan
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin Hydrochloride
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
Obimet
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
25
Nebivololapproved, investigationalPhase 381152520-56-4, 99200-09-671301
Synonyms:
1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol
1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol
104365-59-5
118457-14-0
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
99200-09-6
AC-1611
AC1L2FX8
AC1Q4OMF
Bystolic
C22H25F2NO4
CHEMBL434394
CID71301
D05127
DB04861
I06-0378
L001284
LS-178404
Lobivon
MolPort-003-849-343
Nebicard-5
 
Nebilet
Nebilong
Nebipill
Nebivolol
Nebivolol (USAN/INN)
Nebivolol [USAN:INN:BAN]
Nebivolol hydrochloride
Nebivololum
Nebivololum [Latin]
Nebivololum [latin]
Nubeta
PDSP1_000244
PDSP2_000243
PI-21858
R 67555
R-67555
R65,824
UNII-030Y90569U
alpha,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,Alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)
alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol)
alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
26
EplerenoneapprovedPhase 389107724-20-9150310, 443872
Synonyms:
107724-20-9
7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone
AC-4213
AC1L9FDC
C12512
CGP-30083
CHEBI:31547
CHEBI:726453
CHEMBL1095097
CID443872
D01115
Eplerenone
 
Eplerenone (JAN/USAN/INN)
Epoxymexrenone
Inspra
Inspra (TN)
Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone
MolPort-003-986-216
NCGC00159559-01
NCGC00159559-02
S1707_Selleck
SC-66110
Selara
TL8000270
ZINC03985982
27
SpironolactoneapprovedPhase 31591952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
28
Creatineapproved, nutraceuticalPhase 2, Phase 311057-00-1586
Synonyms:
((amino(Imino)methyl)(methyl)amino)acetic acid
((amino(imino)methyl)(methyl)amino)acetate
((amino(imino)methyl)(methyl)amino)acetic acid
(N-methylcarbamimidamido)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(α-methylguanido)acetic acid
Cosmocair C 100
Creatin
Creatine
Creatine hydrate
Kreatin
 
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-Methyl-Glycine
N-(aminoiminomethyl)-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
Phosphagen
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetic acid
29DeflazacortPhase 3, Phase 11214484-47-0
30Immunosuppressive AgentsPhase 3, Phase 110422
31UbiquinonePhase 2, Phase 392
32VitaminsPhase 2, Phase 33857
33Trace ElementsPhase 2, Phase 33900
34MicronutrientsPhase 2, Phase 33901
35Pharmaceutical SolutionsPhase 3, Phase 2, Phase 17004
36Adrenergic AgonistsPhase 32331
37Immunologic FactorsPhase 3, Phase 2, Phase 118483
38Hypoglycemic AgentsPhase 3, Phase 2, Phase 14503
39idebenonePhase 3, Phase 219
40AntioxidantsPhase 3, Phase 2, Phase 12442
41
EnalaprilatPhase 311276420-72-96917719
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
76420-72-9
AC1NUWEA
AC1OCEK7
BIDD:GT0752
C11720
C18H24N2O5.2H2O
CHEBI:116759
CHEBI:42302
CHEBI:4786
CHEBI:59877
CHEMBL1200697
CHEMBL577
CID5462501
CID6917719
CPD000466359
D03769
EAL
ENALAPRILAT INHIBITOR
Enalapril acid
Enalapril diacid
 
Enalaprilat
Enalaprilat (USP)
Enalaprilat anhydrous
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalprilate hydrate
HMS2051H16
HMS2089P04
LS-118903
LS-187219
MK-422
MLS000759476
MLS001424138
MolPort-005-943-792
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline--water (1/2)
NCGC00164593-01
S1657_Selleck
SAM001246684
SBB065733
SMR000466359
Vasotec I.V.
enalprilat hydrate
42Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 2, Phase 19988
43HormonesPhase 3, Phase 2, Phase 111748
44glucocorticoidsPhase 3, Phase 2, Phase 13896
45Antineoplastic Agents, HormonalPhase 3, Phase 24256
46Anti-Inflammatory AgentsPhase 3, Phase 2, Phase 18478
47Hormone AntagonistsPhase 3, Phase 2, Phase 110002
48Protective AgentsPhase 3, Phase 2, Phase 15651
49DiphosphonatesPhase 3381
50
Zoledronic acidPhase 3286118072-93-868740
Synonyms:
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
AKOS005145739
Aclasta
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42'446
CGP 42446
CGP 42446A
CGP-42'446
CGP-42446
CHEBI:46557
CHEMBL924
CID68740
D08689
 
DB00399
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
NSC721517
Novartis brand of zoledronic acid
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
ZOL
Zoledronate
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)

Interventional clinical trials:

(show top 50)    (show all 179)
idNameStatusNCT IDPhase
1Tadalafil in Becker Muscular DystrophyCompletedNCT01070511Phase 4
2Ramipril Versus Carvedilol in Duchenne and Becker PatientsRecruitingNCT00819845Phase 4
3The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular DystrophyRecruitingNCT00606775Phase 4
4Stacking Exercises Aid the Decline in FVC and Sick TimeRecruitingNCT01999075Phase 4
5PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular DystrophyActive, not recruitingNCT02207283Phase 4
6Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)CompletedNCT00592553Phase 2, Phase 3
7High-dose Prednisone in Duchenne Muscular DystrophyCompletedNCT00110669Phase 3
8Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy TrialCompletedNCT02432885Phase 3
9Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular DystrophyCompletedNCT00004646Phase 3
10A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular DystrophyCompletedNCT01254019Phase 3
11Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)CompletedNCT01027884Phase 3
12Creatine and Glutamine in Steroid-Naive Duchenne Muscular DystrophyCompletedNCT00016653Phase 2, Phase 3
13A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)CompletedNCT00018109Phase 3
14Effects of Sodium Nitrate on Blood Flow in Becker Muscular DystrophyRecruitingNCT02147639Phase 2, Phase 3
15L-citrulline and Metformin in Duchenne's Muscular DystrophyRecruitingNCT01995032Phase 3
16Finding the Optimum Regimen for Duchenne Muscular DystrophyRecruitingNCT01603407Phase 3
17Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular DystrophyRecruitingNCT02354352Phase 3
18Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular DystrophyRecruitingNCT01648634Phase 3
19Confirmatory Study of Eteplirsen in DMD PatientsRecruitingNCT02255552Phase 3
20A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian SubjectsRecruitingNCT01803412Phase 3
21A Research Study of Zoledronic Acid in Children and Adolescents With OsteoporosisRecruitingNCT00799266Phase 3
22Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyActive, not recruitingNCT01183767Phase 2, Phase 3
23Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular DystrophyActive, not recruitingNCT01826487Phase 3
24Study of Ataluren for Previously Treated Patients With nmDBMD in the USEnrolling by invitationNCT01247207Phase 3
25Study of Ataluren for Previously Treated Patients With nmDBMD in Europe, Israel, Australia, and CanadaEnrolling by invitationNCT01557400Phase 3
26Extension Study of Drisapersen in DMD SubjectsEnrolling by invitationNCT02636686Phase 3
27Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular DystrophiesEnrolling by invitationNCT01126697Phase 2, Phase 3
28Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation DystrophinopathyEnrolling by invitationNCT02090959Phase 3
29Study of SRP-4045 and SRP-4053 in DMD PatientsNot yet recruitingNCT02500381Phase 3
30Phase 2b Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)TerminatedNCT00847379Phase 2, Phase 3
31A Study of Tadalafil for Duchenne Muscular DystrophyTerminatedNCT01865084Phase 3
32Open Label Study of GSK2402968 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01480245Phase 3
33CoQ10 and Prednisone in Non-Ambulatory DMDTerminatedNCT00308113Phase 3
34Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular DisordersTerminatedNCT00839033Phase 3
35Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment ProtocolWithdrawnNCT01890798Phase 3
36L-citrulline and Metformin in Becker's Muscular DystrophyCompletedNCT02018731Phase 2
37CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic CarriersCompletedNCT01540604Phase 2
38Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy PatientsCompletedNCT01350154Phase 2
39Safety and Efficacy Study of PTC124 in Duchenne Muscular DystrophyCompletedNCT00264888Phase 2
40Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular DystrophyCompletedNCT00159250Phase 1, Phase 2
41Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular DystrophyCompletedNCT00654784Phase 2
42Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)CompletedNCT00758225Phase 2
43Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy PatientsCompletedNCT01396239Phase 2
44A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)CompletedNCT01462292Phase 2
45Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)CompletedNCT01037309Phase 1, Phase 2
46Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) PatientsCompletedNCT00844597Phase 1, Phase 2
47Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular DystrophyCompletedNCT00296621Phase 2
48Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular DystrophyCompletedNCT01153932Phase 2
49Pentoxifylline in Duchenne Muscular DystrophyCompletedNCT00102453Phase 1, Phase 2
50Study Evaluating MYO-029 in Adult Muscular DystrophyCompletedNCT00104078Phase 1, Phase 2

Search NIH Clinical Center for Becker Muscular Dystrophy

Genetic Tests for Becker Muscular Dystrophy

About this section

Genetic tests related to Becker Muscular Dystrophy:

id Genetic test Affiliating Genes
1 Becker Muscular Dystrophy22

Anatomical Context for Becker Muscular Dystrophy

About this section

MalaCards organs/tissues related to Becker Muscular Dystrophy:

33
Skeletal muscle, Heart, Bone, Liver, Myeloid, Testes, Lung

Animal Models for Becker Muscular Dystrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Becker Muscular Dystrophy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00036317.7DMD, FKRP, FKTN, LAMA2, NOS1, SNTA1
2MP:00053867.6DMD, DYSF, FKRP, FKTN, LAMA2, NOS1
3MP:00053766.8DMD, DYSF, FKRP, FKTN, LAMA2, MYF6
4MP:00053696.2DMD, DYSF, FKRP, FKTN, LAMA2, MYF6

Publications for Becker Muscular Dystrophy

About this section

Articles related to Becker Muscular Dystrophy:

(show top 50)    (show all 491)
idTitleAuthorsYear
1
Is there a family profile of addictive behaviors? Family functioning in anorexia nervosa and drug dependence disorder. (23794317)
2014
2
Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines. (24171172)
2013
3
Fasting blood sugar and serum triglyceride as the risk factors of colorectal adenoma in korean population receiving screening colonoscopy. (23429421)
2013
4
The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine. (23329579)
2013
5
Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: Activation of VEGF- PI3K/Akte-NOS pathway. (24247795)
2013
6
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. (22132711)
2013
7
The efficacy of outpatient and community-based aphasia group interventions: a systematic review. (23336826)
2013
8
Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells. (22797702)
2012
9
Convergence of genome-wide association and candidate gene studies for alcoholism. (22978509)
2012
10
E2F1 inhibits MDM2 expression in a p53-dependent manner. (20837136)
2011
11
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients. (21738656)
2011
12
Planned caesarean hysterectomy versus "conserving" caesarean section in patients with placenta accreta. (22014777)
2011
13
ATF3 represses PDX-1 expression in pancreatic I^-cells. (21821004)
2011
14
An open study of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis: efficacy, complications and outcome. (20041929)
2011
15
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes. (21573905)
2011
16
Thymoma: Results of treatment and role of radiotherapy. (24376917)
2010
17
Sonographic diagnosis of brain malformations, part 2: holoprosencephaly - hydranencephaly - agenesis of septum pellucidum - schizencephaly - septo-optical dysplasia. (21117007)
2010
18
Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study. (19159951)
2010
19
Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. (19897077)
2009
20
Operative treatment of plantar fasciitis preserving the function of the plantar fascia: technique tip. (19796599)
2009
21
Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines. (18191450)
2008
22
Pressure necrosis masquerading as a burn injury in a patient with a cervical epidural abscess producing acute quadriplegia. (18535478)
2008
23
Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats. (18344376)
2008
24
Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases. (17638668)
2007
25
High expression of KIF14 in retinoblastoma: association with older age at diagnosis. (17962437)
2007
26
Neurodevelopmental outcome of very-low-birth-weight infants with chorioamnionitis. (18265542)
2007
27
Severe congenital neutropenia: genetics and pathogenesis. (18528462)
2006
28
Effect of an antibacterial adhesive on the bond strength of three different luting resin composites. (16288949)
2006
29
Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome. (17162366)
2006
30
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. (16606927)
2006
31
S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells. (16840547)
2006
32
The regulation of glucose effectiveness: how glucose modulates its own production. (15930973)
2005
33
Alpha-thalassemia/mental retardation syndrome in a 45,X male. (15633163)
2005
34
Targeted therapies for cancer 2004. (15487459)
2004
35
The endothelial protein C receptor (EPCR) 23bp insert in patients with myocardial infarction. (11341520)
2001
36
Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. (10852523)
2000
37
Aplastic anemia and paroxysmal nocturnal hemoglobinuria: a follow-up study of the glycosylphosphatidylinositol-anchored proteins defect. (11920198)
2000
38
Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens. (10655992)
1999
39
A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. (9702741)
1998
40
Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice. (9661901)
1998
41
Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. (9736607)
1998
42
Fibroblast membrane sterol kinetic domains: modulation by sterol carrier protein-2 and liver fatty acid binding protein. (8895052)
1996
43
Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures. (7718002)
1995
44
Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide. (7707313)
1995
45
Target for anti-ulcer agents--pH, H. pylori or NO?]. (8139901)
1994
46
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha. (7999419)
1994
47
Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor beta-subunit. (7693677)
1993
48
Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate. (1566745)
1992
49
Expression of c-fos, c-jun and jun B in peripheral blood lymphocytes from young and elderly adults. (1434944)
1992
50
APPENDICEAL CARCINOID WITH CARCINOID SYNDROME. (14166209)
1964

Variations for Becker Muscular Dystrophy

About this section

UniProtKB/Swiss-Prot genetic disease variations for Becker Muscular Dystrophy:

67
id Symbol AA change Variation ID SNP ID
1DMDp.Ala168AspVAR_005149
2DMDp.Tyr231AsnVAR_005150
3DMDp.His2921ArgVAR_005170rs1800279
4DMDp.Ala3421ValVAR_005172
5DMDp.Ala171ProVAR_023539

Clinvar genetic disease variations for Becker Muscular Dystrophy:

5 (show all 143)
id Gene Variation Type Significance SNP ID Assembly Location
1DMDNM_004006.2(DMD): c.10108C> T (p.Arg3370Ter)single nucleotide variantPathogenicrs104894787GRCh37Chr X, 31196901: 31196901
2DMDDMD, IVS19, A-C, +3single nucleotide variantPathogenic
3DMDDMD, IVS57, G-C, -1single nucleotide variantPathogenic
4DMDNM_004006.2(DMD): c.503C> A (p.Ala168Asp)single nucleotide variantPathogenicrs128626236GRCh37Chr X, 32834612: 32834612
5DMDDMD, IVS2, G-T, -1single nucleotide variantPathogenic
6DMDNM_004006.2(DMD): c.691T> A (p.Tyr231Asn)single nucleotide variantPathogenicrs128626237GRCh37Chr X, 32717369: 32717369
7DMDBMD, IVS13, G-T, -1single nucleotide variantPathogenic
8DMDNM_004006.2(DMD): c.6373C> T (p.Gln2125Ter)single nucleotide variantPathogenicrs128626251GRCh37Chr X, 32235098: 32235098
9DMDNM_004006.2(DMD): c.8762A> G (p.His2921Arg)single nucleotide variantPathogenicrs1800279GRCh37Chr X, 31496398: 31496398
10DMDNM_004006.2(DMD): c.10262C> T (p.Ala3421Val)single nucleotide variantPathogenicrs104894791GRCh37Chr X, 31196049: 31196049
11DMDDMD, 1-BP DEL, 10683CdeletionPathogenic
12DMDNM_004006.2(DMD): c.3631G> T (p.Glu1211Ter)single nucleotide variantPathogenicrs267606771GRCh37Chr X, 32466728: 32466728
13DMDNM_004006.2(DMD): c.9568C> T (p.Arg3190Ter)single nucleotide variantPathogenicrs104894797GRCh37Chr X, 31224780: 31224780
14DMDNM_004006.2(DMD): c.3940C> T (p.Arg1314Ter)single nucleotide variantPathogenicrs5030730GRCh37Chr X, 32456489: 32456489
15DMDNM_004006.2(DMD): c.9225-285A> Gsingle nucleotide variantPathogenicrs587776747GRCh37Chr X, 31279418: 31279418
16DMDDMD, IVS25, A-G, +2036single nucleotide variantPathogenic
17DMDNM_004006.2(DMD): c.8713C> T (p.Arg2905Ter)single nucleotide variantPathogenicrs128627256GRCh37Chr X, 31496447: 31496447
18DMDNM_000109.3(DMD): c.1700T> C (p.Leu567Pro)single nucleotide variantPathogenicrs370644567GRCh37Chr X, 32591735: 32591735
19DMDNM_004006.2(DMD): c.1812+1G> Asingle nucleotide variantLikely pathogenic, Pathogenicrs373286166GRCh37Chr X, 32591646: 32591646
20DMDNM_004006.2(DMD): c.9164-1G> Csingle nucleotide variantPathogenicrs398124082GRCh37Chr X, 31341776: 31341776
21DMDNM_004006.2(DMD): c.8680G> T (p.Glu2894Ter)single nucleotide variantPathogenicrs727503802GRCh37Chr X, 31496480: 31496480
22DMDNM_004006.2(DMD): c.5363C> G (p.Ser1788Ter)single nucleotide variantPathogenicrs199774535GRCh37Chr X, 32366608: 32366608
23DMDNM_004006.2(DMD): c.4806A> T (p.Gly1602=)single nucleotide variantPathogenicrs727503830GRCh37Chr X, 32398666: 32398666
24DMDNM_004006.2(DMD): c.3532G> T (p.Glu1178Ter)single nucleotide variantPathogenicrs727503836GRCh37Chr X, 32472850: 32472850
25DMDNM_004006.2(DMD): c.2956C> T (p.Gln986Ter)single nucleotide variantPathogenicrs727503844GRCh37Chr X, 32486821: 32486821
26DMDNM_004006.2(DMD): c.2755A> T (p.Lys919Ter)single nucleotide variantPathogenicrs727503850GRCh37Chr X, 32503084: 32503084
27DMDNM_004006.2(DMD): c.2484T> G (p.Tyr828Ter)single nucleotide variantPathogenicrs727503858GRCh37Chr X, 32509532: 32509532
28DMDNM_004006.2(DMD): c.883C> T (p.Arg295Ter)single nucleotide variantPathogenicrs727503864GRCh37Chr X, 32716064: 32716064
29DMDNM_004006.2(DMD): c.14_15delAAinsT (p.Glu5Valfs)indelPathogenicrs796065325GRCh37Chr X, 33229415: 33229416
30DMDNM_004006.2(DMD): c.1093C> T (p.Gln365Ter)single nucleotide variantPathogenicrs794726993GRCh37Chr X, 32663137: 32663137
31DMDNM_004006.2(DMD): c.1070delC (p.Ser357Leufs)deletionPathogenicrs794726994GRCh37Chr X, 32663160: 32663160
32DMDNM_004006.2(DMD): c.1286C> G (p.Ser429Ter)single nucleotide variantPathogenicrs398123853GRCh37Chr X, 32662294: 32662294
33DMDNM_004006.2(DMD): c.1150-2A> Gsingle nucleotide variantPathogenicrs794727030GRCh37Chr X, 32662432: 32662432
34DMDNM_004006.2(DMD): c.1533_1536delTCAC (p.His512Trpfs)deletionPathogenicrs794727097GRCh37Chr X, 32613940: 32613943
35DMDNM_004006.2(DMD): c.1704+1G> Asingle nucleotide variantPathogenicrs794727123GRCh37Chr X, 32591861: 32591861
36DMDNM_004006.2(DMD): c.1912C> T (p.Gln638Ter)single nucleotide variantPathogenicrs794727170GRCh37Chr X, 32583899: 32583899
37DMDNM_004006.2(DMD): c.2601_2602delAA (p.Gln869Valfs)deletionPathogenicrs794727322GRCh37Chr X, 32509414: 32509415
38DMDNM_004006.2(DMD): c.2803+1G> Csingle nucleotide variantPathogenicrs398123908GRCh37Chr X, 32503035: 32503035
39DMDNM_004006.2(DMD): c.2804-2A> Tsingle nucleotide variantPathogenicrs794727357GRCh37Chr X, 32490428: 32490428
40DMDNM_004006.2(DMD): c.2815_2816delTT (p.Leu939Alafs)deletionPathogenicrs794727358GRCh38Chr X, 32472297: 32472298
41DMDNM_004006.2(DMD): c.2933_2934delGA (p.Arg978Thrfs)deletionPathogenicrs794727359GRCh37Chr X, 32490296: 32490297
42DMDNM_004006.2(DMD): c.3497_3500delTATC (p.Leu1166Glnfs)deletionPathogenicrs794727421GRCh37Chr X, 32472882: 32472885
43DMDNM_004006.2(DMD): c.3535G> T (p.Glu1179Ter)single nucleotide variantPathogenicrs794727422GRCh37Chr X, 32472847: 32472847
44DMDNM_004006.2(DMD): c.3838A> T (p.Lys1280Ter)single nucleotide variantPathogenicrs794727463GRCh37Chr X, 32459380: 32459380
45DMDNM_004006.2(DMD): c.133C> T (p.Gln45Ter)single nucleotide variantPathogenicrs794727499GRCh37Chr X, 32867898: 32867898
46DMDNM_004006.2(DMD): c.4315A> T (p.Arg1439Ter)single nucleotide variantPathogenicrs794727550GRCh37Chr X, 32408217: 32408217
47DMDNM_004006.2(DMD): c.4523delT (p.Leu1508Cysfs)deletionPathogenicrs794727567GRCh37Chr X, 32404578: 32404578
48DMDNM_004006.2(DMD): c.4675-2A> Gsingle nucleotide variantPathogenicrs794727575GRCh37Chr X, 32398799: 32398799
49DMDNM_004006.2(DMD): c.5697delA (p.Lys1899Asnfs)deletionPathogenicrs794727661GRCh38Chr X, 32343176: 32343176
50DMDNM_004006.2(DMD): c.6238delC (p.Gln2080Serfs)deletionPathogenicrs794727672GRCh37Chr X, 32305698: 32305698
51DMDNM_004006.2(DMD): c.6673_6674insGTTT (p.Leu2225Cysfs)insertionPathogenicrs797044743GRCh37Chr X, 31950285: 31950286
52DMDNM_004006.2(DMD): c.6982A> T (p.Lys2328Ter)single nucleotide variantPathogenicrs754896795GRCh38Chr X, 31875304: 31875304
53DMDNM_004006.2(DMD): c.291dupT (p.Asp98Terfs)duplicationPathogenicrs797044756GRCh38Chr X, 32823361: 32823361
54DMDNM_004006.2(DMD): c.7247dupT (p.Leu2416Phefs)duplicationPathogenicrs797044764GRCh37Chr X, 31838154: 31838154
55DMDNM_004006.2(DMD): c.7295_7296delCC (p.Thr2432Asnfs)deletionPathogenicrs794727746GRCh37Chr X, 31838105: 31838106
56DMDNM_004006.2(DMD): c.7444delC (p.Thr2483Profs)deletionPathogenicrs794727749GRCh37Chr X, 31792175: 31792175
57DMDNM_004006.2(DMD): c.8184delC (p.Lys2729Argfs)deletionPathogenicrs794727763GRCh37Chr X, 31645823: 31645823
58DMDNM_004006.2(DMD): c.8656C> T (p.Gln2886Ter)single nucleotide variantPathogenicrs201361100GRCh37Chr X, 31497112: 31497112
59DMDNM_004006.2(DMD): c.8669-2A> Csingle nucleotide variantPathogenicrs794727770GRCh37Chr X, 31496493: 31496493
60DMDNM_004006.2(DMD): c.415_428delATTCTCCTGAGCTG (p.Ile139Glyfs)deletionPathogenicrs794727795GRCh37Chr X, 32834687: 32834700
61DMDNM_004006.2(DMD): c.9216C> G (p.Tyr3072Ter)single nucleotide variantPathogenicrs794727820GRCh37Chr X, 31341723: 31341723
62DMDNM_004006.2(DMD): c.9978C> G (p.Tyr3326Ter)single nucleotide variantPathogenicrs794727832GRCh37Chr X, 31198595: 31198595
63DMDNM_004006.2(DMD): c.565C> T (p.Gln189Ter)single nucleotide variantPathogenicrs794727861GRCh37Chr X, 32827694: 32827694
64DMDNM_004006.2(DMD): c.547dupT (p.Trp183Leufs)duplicationPathogenicrs796065333GRCh38Chr X, 32809595: 32809595
65DMDNM_004006.2(DMD): c.627delA (p.Ile209Metfs)deletionPathogenicrs794727862GRCh37Chr X, 32827632: 32827632
66DMDNM_004006.2(DMD): c.10554-2A> Gsingle nucleotide variantPathogenicrs794727890GRCh37Chr X, 31165637: 31165637
67DMDNM_004006.2(DMD): c.9G> A (p.Trp3Ter)single nucleotide variantPathogenicrs398122853GRCh37Chr X, 33229421: 33229421
68DMDNM_004006.2(DMD): c.10033C> T (p.Arg3345Ter)single nucleotide variantPathogenicrs398123827GRCh37Chr X, 31198540: 31198540
69DMDNM_004006.2(DMD): c.10086+1G> Asingle nucleotide variantPathogenicrs398123828GRCh37Chr X, 31198486: 31198486
70DMDNM_004006.2(DMD): c.1012G> T (p.Glu338Ter)single nucleotide variantPathogenicrs398123830GRCh37Chr X, 32663218: 32663218
71DMDNM_004006.2(DMD): c.10171C> T (p.Arg3391Ter)single nucleotide variantPathogenicrs398123832GRCh37Chr X, 31196838: 31196838
72DMDNM_004019.2(DMD): c.1020G> A (p.Thr340=)single nucleotide variantPathogenicrs398123834GRCh37Chr X, 31196785: 31196785
73DMDNM_004006.2(DMD): c.10446_10447delCT (p.Ser3483Profs)deletionPathogenicrs398123837GRCh37Chr X, 31187666: 31187667
74DMDNM_004006.2(DMD): c.1048G> T (p.Glu350Ter)single nucleotide variantPathogenicrs398123840GRCh37Chr X, 32663182: 32663182
75DMDNM_004006.2(DMD): c.1261C> T (p.Gln421Ter)single nucleotide variantPathogenicrs398123852GRCh37Chr X, 32662319: 32662319
76DMDNM_004006.2(DMD): c.1306dupG (p.Val436Glyfs)duplicationPathogenicrs398123854GRCh37Chr X, 32662274: 32662274
77DMDNM_004006.2(DMD): c.1332-9A> Gsingle nucleotide variantPathogenicrs72468700GRCh37Chr X, 32632579: 32632579
78DMDNM_004006.2(DMD): c.1341_1342dupAG (p.Val448Glufs)duplicationPathogenicrs398123856GRCh37Chr X, 32632560: 32632561
79DMDNM_004006.2(DMD): c.1371delG (p.Glu459Serfs)deletionPathogenicrs398123857GRCh37Chr X, 32632531: 32632531
80DMDNM_004006.2(DMD): c.1465C> T (p.Gln489Ter)single nucleotide variantPathogenicrs398123861GRCh37Chr X, 32632437: 32632437
81DMDNM_004006.2(DMD): c.1482+1G> Tsingle nucleotide variantPathogenicrs398123862GRCh37Chr X, 32632419: 32632419
82DMDNM_004006.2(DMD): c.1529_1530delTC (p.Leu510Hisfs)deletionPathogenicrs398123863GRCh37Chr X, 32613946: 32613947
83DMDNM_004006.2(DMD): c.1615C> T (p.Arg539Ter)single nucleotide variantPathogenicrs398123865GRCh37Chr X, 32591951: 32591951
84DMDNM_004006.2(DMD): c.1886C> A (p.Ser629Ter)single nucleotide variantPathogenicrs398123867GRCh37Chr X, 32583925: 32583925
85DMDNM_004006.2(DMD): c.1990C> T (p.Gln664Ter)single nucleotide variantPathogenicrs398123870GRCh37Chr X, 32583821: 32583821
86DMDNM_004006.2(DMD): c.2032C> T (p.Gln678Ter)single nucleotide variantPathogenicrs398123872GRCh37Chr X, 32563412: 32563412
87DMDNM_004006.2(DMD): c.2125delC (p.Gln709Lysfs)deletionPathogenicrs398123875GRCh37Chr X, 32563319: 32563319
88DMDNM_004006.2(DMD): c.2294_2297delCCAT (p.Ala765Glufs)deletionPathogenicrs398123882GRCh37Chr X, 32519955: 32519958
89DMDNM_004006.2(DMD): c.2332C> T (p.Gln778Ter)single nucleotide variantPathogenicrs398123883GRCh37Chr X, 32519920: 32519920
90DMDNM_004006.2(DMD): c.2380+1G> Csingle nucleotide variantPathogenicrs398123884GRCh37Chr X, 32519871: 32519871
91DMDNM_004006.2(DMD): c.2381-1G> Tsingle nucleotide variantPathogenicrs398123887GRCh37Chr X, 32509636: 32509636
92DMDNM_004006.2(DMD): c.2419C> T (p.Gln807Ter)single nucleotide variantPathogenicrs398123888GRCh37Chr X, 32509597: 32509597
93DMDNM_004006.2(DMD): c.2547delT (p.Glu850Lysfs)deletionPathogenicrs398123895GRCh37Chr X, 32509469: 32509469
94DMDNM_004006.2(DMD): c.2650C> T (p.Gln884Ter)single nucleotide variantPathogenicrs398123903GRCh37Chr X, 32503189: 32503189
95DMDNM_004006.2(DMD): c.2804-1G> Asingle nucleotide variantPathogenicrs398123909GRCh37Chr X, 32490427: 32490427
96DMDNM_004006.2(DMD): c.2816T> A (p.Leu939Ter)single nucleotide variantPathogenicrs398123910GRCh37Chr X, 32490414: 32490414
97DMDNM_004006.2(DMD): c.28delT (p.Cys10Valfs)deletionPathogenicrs398123913GRCh37Chr X, 33229402: 33229402
98DMDNM_004006.2(DMD): c.31+1G> Tsingle nucleotide variantPathogenicrs398123923GRCh37Chr X, 33229398: 33229398
99DMDNM_004006.2(DMD): c.3276+1G> Asingle nucleotide variantPathogenicrs398123934GRCh37Chr X, 32482702: 32482702
100DMDNM_004006.2(DMD): c.3295C> T (p.Gln1099Ter)single nucleotide variantPathogenicrs398123935GRCh37Chr X, 32481693: 32481693
101DMDNM_004006.2(DMD): c.336G> A (p.Trp112Ter)single nucleotide variantPathogenicrs398123936GRCh37Chr X, 32841433: 32841433
102DMDNM_004006.2(DMD): c.3432+1G> Asingle nucleotide variantPathogenicrs398123937GRCh37Chr X, 32481555: 32481555
103DMDNM_004006.2(DMD): c.3580C> T (p.Gln1194Ter)single nucleotide variantPathogenicrs398123942GRCh37Chr X, 32472802: 32472802
104DMDNM_004006.2(DMD): c.3603+2T> Asingle nucleotide variantPathogenicrs146071084GRCh37Chr X, 32472777: 32472777
105DMDNM_004006.2(DMD): c.3639dupA (p.Val1214Serfs)duplicationPathogenicrs398123943GRCh37Chr X, 32466720: 32466720
106DMDNM_004006.2(DMD): c.3747delG (p.Trp1249Cysfs)deletionPathogenicrs398123945GRCh37Chr X, 32466612: 32466612
107DMDNM_004006.2(DMD): c.3779_3785delCTTTGGAinsGG (p.Thr1260Argfs)indelPathogenicrs398123946GRCh37Chr X, 32466574: 32466580
108DMDNM_004006.2(DMD): c.4117C> T (p.Gln1373Ter)single nucleotide variantPathogenicrs398123948GRCh37Chr X, 32429985: 32429985
109DMDNM_004006.2(DMD): c.412_413delAA (p.Lys138Aspfs)deletionPathogenicrs398123949GRCh37Chr X, 32834702: 32834703
110DMDNM_004006.2(DMD): c.4471_4472delAA (p.Lys1491Glufs)deletionPathogenicrs398123957GRCh37Chr X, 32407664: 32407665
111DMDNM_004006.2(DMD): c.4534_4535delCT (p.Leu1512Glufs)deletionPathogenicrs398123961GRCh37Chr X, 32404566: 32404567
112DMDNM_004006.2(DMD): c.4545_4549delGAAGT (p.Lys1516Terfs)deletionPathogenicrs398123962GRCh37Chr X, 32404552: 32404556
113DMDNM_004006.2(DMD): c.5124_5127delGAAA (p.Lys1708Asnfs)deletionPathogenicrs398123979GRCh37Chr X, 32382726: 32382729
114DMDNM_004006.2(DMD): c.5287C> T (p.Arg1763Ter)single nucleotide variantPathogenicrs398123981GRCh37Chr X, 32380943: 32380943
115DMDNM_004006.2(DMD): c.5530C> T (p.Arg1844Ter)single nucleotide variantPathogenicrs1064325GRCh37Chr X, 32364116: 32364116
116DMDNM_004006.2(DMD): c.5640T> A (p.Tyr1880Ter)single nucleotide variantPathogenicrs398123993GRCh37Chr X, 32361350: 32361350
117DMDNM_004006.2(DMD): c.583C> T (p.Arg195Ter)single nucleotide variantPathogenicrs398123999GRCh37Chr X, 32827676: 32827676
118DMDNM_004006.2(DMD): c.5938G> T (p.Glu1980Ter)single nucleotide variantPathogenicrs398124001GRCh37Chr X, 32328378: 32328378
119DMDNM_004006.2(DMD): c.6000T> A (p.Tyr2000Ter)single nucleotide variantPathogenicrs398124002GRCh37Chr X, 32328316: 32328316
120DMDNM_004006.2(DMD): c.6072T> A (p.Cys2024Ter)single nucleotide variantPathogenicrs373804251GRCh37Chr X, 32328244: 32328244
121DMDNM_004006.2(DMD): c.615T> A (p.Tyr205Ter)single nucleotide variantPathogenicrs398124004GRCh37Chr X, 32827644: 32827644
122DMDNM_004006.2(DMD): c.6182delC (p.Ala2061Glufs)deletionPathogenicrs398124005GRCh37Chr X, 32305754: 32305754
123DMDNM_004006.2(DMD): c.649+1G> Asingle nucleotide variantPathogenicrs398124032GRCh37Chr X, 32827609: 32827609
124DMDNM_004006.2(DMD): c.6906G> A (p.Trp2302Ter)single nucleotide variantPathogenicrs398124036GRCh37Chr X, 31947719: 31947719
125DMDNM_004006.2(DMD): c.7189C> T (p.Gln2397Ter)single nucleotide variantPathogenicrs398124042GRCh37Chr X, 31854846: 31854846
126DMDNM_004006.2(DMD): c.7309+1G> Asingle nucleotide variantPathogenicrs398124044GRCh37Chr X, 31838091: 31838091
127DMDNM_004006.2(DMD): c.7657C> T (p.Arg2553Ter)single nucleotide variantPathogenicrs398124050GRCh37Chr X, 31747751: 31747751
128DMDNM_004006.2(DMD): c.7682G> A (p.Trp2561Ter)single nucleotide variantPathogenicrs398124052GRCh37Chr X, 31697682: 31697682
129DMDNM_004006.2(DMD): c.7683G> A (p.Trp2561Ter)single nucleotide variantPathogenicrs398124053GRCh37Chr X, 31697681: 31697681
130DMDNM_004006.2(DMD): c.7894C> T (p.Gln2632Ter)single nucleotide variantPathogenicrs398124058GRCh37Chr X, 31676240: 31676240
131DMDNM_004006.2(DMD): c.8064_8065delTA (p.His2688Glnfs)deletionPathogenicrs398124060GRCh37Chr X, 31645942: 31645943
132DMDNM_004006.2(DMD): c.8374_8375delAA (p.Lys2792Valfs)deletionPathogenicrs398124070GRCh37Chr X, 31525413: 31525414
133DMDNM_004006.2(DMD): c.8608C> T (p.Arg2870Ter)single nucleotide variantPathogenicrs398124074GRCh37Chr X, 31497160: 31497160
134DMDNM_004006.2(DMD): c.8652_8653delCT (p.Tyr2885Profs)deletionPathogenicrs398124075GRCh37Chr X, 31497115: 31497116
135DMDNM_004006.2(DMD): c.8912_8913delTC (p.Leu2971Profs)deletionPathogenicrs398124078GRCh37Chr X, 31496247: 31496248
136DMDNM_004006.2(DMD): c.9125delA (p.His3042Profs)deletionPathogenicrs398124080GRCh37Chr X, 31366711: 31366711
137DMDNM_004006.2(DMD): c.9225-647A> Gsingle nucleotide variantPathogenicrs398124091GRCh37Chr X, 31279780: 31279780
138DMDNM_004006.2(DMD): c.9337C> T (p.Arg3113Ter)single nucleotide variantPathogenicrs398124092GRCh37Chr X, 31241188: 31241188
139DMDNM_004006.2(DMD): c.9361+1G> Asingle nucleotide variantPathogenicrs398124094GRCh37Chr X, 31241163: 31241163
140DMDNM_004006.2(DMD): c.9361+1G> Csingle nucleotide variantPathogenicrs398124094GRCh37Chr X, 31241163: 31241163
141DMDNM_004006.2(DMD): c.9564-1G> Asingle nucleotide variantPathogenicrs398124096GRCh37Chr X, 31224785: 31224785
142DMDNM_004006.2(DMD): c.9650-2A> Gsingle nucleotide variantPathogenicrs398124100GRCh37Chr X, 31222237: 31222237
143DMDNM_004006.2(DMD): c.9862G> T (p.Glu3288Ter)single nucleotide variantPathogenicrs398124106GRCh37Chr X, 31200967: 31200967

Expression for genes affiliated with Becker Muscular Dystrophy

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Becker Muscular Dystrophy patients vs. healthy controls: 32
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1MYH3myosin, heavy chain 3, skeletal muscle, embryonicSkeletal Muscle+4.140.000

Search GEO for disease gene expression data for Becker Muscular Dystrophy.

Pathways for genes affiliated with Becker Muscular Dystrophy

About this section

GO Terms for genes affiliated with Becker Muscular Dystrophy

About this section

Cellular components related to Becker Muscular Dystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1filopodium membraneGO:003152710.2DMD, UTRN
2dystrophin-associated glycoprotein complexGO:001601010.0DMD, FKRP, SGCA
3T-tubuleGO:00303159.7DYSF, NOS1
4sarcolemmaGO:00423839.6DYSF, FKRP
5protein complexGO:00432349.5DMD, SNTA1, UTRN
6cytoskeletonGO:00058569.1SGCA, UTRN, VCL

Biological processes related to Becker Muscular Dystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1skeletal muscle tissue developmentGO:00075199.8DMD, MYF6

Molecular functions related to Becker Muscular Dystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1vinculin bindingGO:001716610.0DMD, UTRN

Sources for Becker Muscular Dystrophy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet